Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. The company is involved in cell preparation product manufacturing; and collection and storage of immune cells. Its products are used in the field of infectious diseases and inflammation, cancer, and oncology. The company was incorporated in 2004 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does 4170 (4170) operate in?
4170 belongs to the Other sector and operates in the Biotechnology industry.
What is 4170 (4170) current stock price?
As of the latest data, 4170 stock price is NT$12.30, with a previous close of NT$12.30.
What is 4170 (4170) current market capitalization?
4170 market cap is approximately 538.39 million.
What is 4170 (4170) Earnings Per Share (EPS)?
The trailing EPS is NT$2.19.
What is 4170 (4170) Price-to-Earnings (P/E) ratio?
4170 current P/E ratio is 5.62.
Does 4170 (4170) pay dividends?
No. 4170 does not pay a dividend.
What is 4170 (4170) beta (volatility) score?
4170 has a beta of 0.379, indicating lower volatility than the overall market.